Cargando…
SUN-374 Management of Congenital Adrenal Hyperplasia in Pregnancy with Female Fetus
Introduction: Dexamethasone (dex) crosses placenta, suppresses fetal ACTH and reduces level of adrenal androgens in fetus with Congenital Adrenal Hyperplasia (CAH). This reduces virilization of female genitalia and its associated risk of emotional distress and need for reconstructive surgery (1). As...
Autores principales: | Kothari, Vallari, Dojki, Farheen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553227/ http://dx.doi.org/10.1210/js.2019-SUN-374 |
Ejemplares similares
-
SUN-361 Reproductive Outcomes in Females with Virilizing Forms of Congenital Adrenal Hyperplasia
por: Falcao, Camila, et al.
Publicado: (2019) -
SUN-167 Treatment Considerations for a Healthy Pregnancy in Women with Classical Congenital Adrenal Hyperplasia (CAH)
por: Calzia, Megan, et al.
Publicado: (2020) -
SUN-174 Giant Bilateral Myelolipomas in a Patient with Congenital Adrenal Hyperplasia
por: Duro, Teodor, et al.
Publicado: (2020) -
SUN-206 A Rare Case of Untreated Congenital Adrenal Hyperplasia Leading to Gender Dysphoria and a Female to Male Transgender
por: Awad, Dana, et al.
Publicado: (2020) -
SUN-197 Giant Adrenal Myelolipoma Associated with Prolonged ACTH Elevation in a Patient with Congenital Adrenal Hyperplasia (CAH)
por: Kaluarachchi, Vidumini, et al.
Publicado: (2020)